CYCLIC NUCLEOTIDES CONCENTRATIONS IN THE CANINE HEART WITH REGIONAL ISCHEMIA : The Role of Cyclic AMP in Ventricular Fibrillation and the Effect of Dibutyryl Cyclic AMP
スポンサーリンク
概要
- 論文の詳細を見る
The effect of the left anterior descending (LAD) coronary artery ligation on myocardial cyclic nucleotides and the role of these nucleotides in the development of ventricular fibrillation (VF) were studied in 135 mongrel dogs by means of sequential punching biopsies from the left ventricle. VF occurred in 50% of the non-premedicated groups. Significant increases of cyclic AMP (c-AMP) concentrations in the ischemic zone were observed after the ligation in VF group. C-AMP concentrations in the ischemic zone were significantly higher after the ligation compared with the border and non-ischemic zone as well as with the non-VF group. They also increased significantly from 30 sec before the onset of VF compared with 2 to 25 min before. No significant change was observed in the control group. In 41 dibutyryl cyclic AMP (DBc-AMP) premedicated dogs, the incidence of VF significantly increased, and c-AMP concentrations were significantly higher than in the non-premedicated group before and after the ligation. They were significantly higher in the ischemic zone 10, 15 and 20 min after the ligation than in the non-ischemic zone. There was a discrepancy of c-AMP concentration between the ischemic zone and the non-ischemic zone in VF induced group, whether DBc-AMP was premedicated or not. Significantly decreased cyclic GMP (c-GMP) levels in the ischemic and the non-ischemic zone were observed after the ligation. C-GMP concentrations with the DBc-AMP premedicated were significantly lower after the ligation compared with the non-premedicated group. Thus, it was concluded that increased c-AMP concentrations in the ischemic zone compared with in the non-ischemic zone had a dangerous tendency to induce VF.
- 社団法人日本循環器学会の論文
- 1984-03-20
著者
-
Ukai Masatoshi
The Second Department Of Internal Medicine Nagoya University School Of Medicine
-
Ogawa Kouichi
The Second Department Of Internal Medicine Nagoya University School Of Medicine
関連論文
- PLASMA LEVEL OF NOREPINEPHRINE, CYCLIC AMP AND CYCLIC GMP IN ESSENTIAL HYPERTENSION
- CHANGES OF PLASMA 6-Keto-PGF_ AND THROMBOXANE B_2 LEVELS AND PLATELET AGGREGATION AFTER TOURNIQUET ISCHEMIA ON THE UPPER LIMB IN NORMAL SUBJECTS AND PATIENTS WITH ISCHEMIC HEART DISEASE
- Endogenous Prostaglandins in Experimental Myocardial Infarction in Canines : The role of released PGE_1 and PGF_2α in the regulation of coronary blood flow after coronary artery occlusion : English Summaries of Original Articles written in Japanese
- Long-term Results of Operated and Non-operated Patients with Congenital Heart Diseases : Natural History and Postoperative Course of Congenital Heart Diseases
- PROSTAGLANDINS AND CYCLIC NUCLEOTIDES: EFFECTS OF PGI_2 AND PGE_1 ON CARDIAC HEMODYNAMIC AND CORONARY ARTERIAL AND MYOCARDIAL CYCLIC NUCLEOTIDE LEVELS IN DOGS
- Myocardial Norepinephrine and Cyclic AMP Concentration following Myocardial Ischemia : Relation to Ventricular Fibrillation and Sudden Death : The Nature of Sudden Death and Its Prevention
- THE DISTRIBUTION OF PLASMA NOREPINEPHRINE CONCENTRATION AND THE RELATION OF PLASMA NOREPINEPHRINE CONCENTRATION TO PULMONARY ARTERIAL PRESSURE IN HEART DISEASE
- SYMPATHETIC NERVOUS SYSTEM IN CHRONIC COR PULMONALE
- LEVELS OF CYCLIC NUCLEOTIDE IN MYOCARDIAL INFARCTION : ESPECIALLY THE ROLE OF c-AMP IN THE DEVELOPMENT OF VENTRICULAR FIBRILLATION : Myocardial Infarction : PROCEEDINGS OF THE 44th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- Studies on Pharmacokinetics of Digoxin in Hyperthyroid and Hypothyroid Dogs
- LONG-TERM EFFECTS OF TRIIODOTHYRONINE AND THIOURACIL ON MYOCARDIAL β-ADRENERGIC RECEPTOR NUMBERS AND CYCLIC AMP CONCENTRATION IN RATS
- CYCLIC NUCLEOTIDES CONCENTRATIONS IN THE CANINE HEART WITH REGIONAL ISCHEMIA : The Role of Cyclic AMP in Ventricular Fibrillation and the Effect of Dibutyryl Cyclic AMP
- Plasma concentrations of 6-keto-prostaglandin F1.ALPHA., thromboxane B2 and platelet aggregation in patients with essential hypertension.